Osaic Holdings
GNOM icon

Osaic Holdings’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Osaic Holdings’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$874 Sell
20
-118
-86% -$5.46K ﹤0.01% 7302
2025
Q4 		$6.31K Sell
138
-248
-64% -$11K ﹤0.01% 6569
2025
Q3 		$5.2K Buy
386
+247
+178% +$8.95K ﹤0.01% 6725
2025
Q2 		$4.68K Sell
139
-1,298
-90% -$41.1K ﹤0.01% 6576
2025
Q1 		$45.7K Sell
1,437
-3,200
-69% -$121K ﹤0.01% 4786
2024
Q4 		$180K Buy
4,637
+12
+0.3% +$504 ﹤0.01% 3696
2024
Q3 		$208K Buy
4,625
+518
+13% +$23.2K ﹤0.01% 3616
2024
Q2 		$171K Buy
4,107
+2,578
+169% +$108K ﹤0.01% 3692
2024
Q1 		$69.6K Buy
1,529
+678
+80% +$30.9K ﹤0.01% 4500
2023
Q4 		$39.3K Sell
851
-297
-26% -$12.1K ﹤0.01% 5060
2023
Q3 		$46.7K Buy
1,148
+175
+18% +$7.97K ﹤0.01% 5044
2023
Q2 		$47.1K Sell
973
-34
-3% -$1.7K ﹤0.01% 4977
2023
Q1 		$49.6K Buy
1,007
+28
+3% +$1.44K ﹤0.01% 4959
2022
Q4 		$48.9K Buy
979
+208
+27% +$10.7K ﹤0.01% 4957
2022
Q3 		$39K Hold
771
– – ﹤0.01% 5074
2022
Q2 		$37K Sell
771
-257
-25% -$13K ﹤0.01% 5177
2022
Q1 		$63K Sell
1,028
-925
-47% -$58.3K ﹤0.01% 4921
2021
Q4 		$156K Buy
1,953
+105
+6% +$8.82K ﹤0.01% 4186
2021
Q3 		$162K Buy
1,848
+774
+72% +$72.5K ﹤0.01% 4096
2021
Q2 		$106K Sell
1,074
-757
-41% -$67.1K ﹤0.01% 4433
2021
Q1 		$165K Buy
1,831
+1,006
+122% +$99.3K ﹤0.01% 3917
2020
Q4 		$79K Sell
825
-200
-20% -$16.7K ﹤0.01% 4226
2020
Q3 		$74K Hold
1,025
– – ﹤0.01% 4038
2020
Q2 		$72K Hold
1,025
– – ﹤0.01% 3924
2020
Q1 		$51K Buy
+1,025
New +$59.3K ﹤0.01% 3954

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Osaic Holdings's GNOM Position: Q1 2026 in Review

Osaic Holdings reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 86% in Q1 2026, selling an estimated $5.46K and leaving 20 shares worth $874. The position accounts for ﹤0.01% of the portfolio, ranked #7302.

Osaic Holdings first reported a position in GNOM in Q1 2020 and has held it in 25 quarters since. The position peaked at $208K in Q3 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Osaic Holdings held 20 shares of Global X Genomics & Biotechnology ETF worth $874 as of Q1 2026.
  • Osaic Holdings sold 118 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $5.46K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7302 holding.
  • Osaic Holdings first reported a position in Global X Genomics & Biotechnology ETF in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Global X Genomics & Biotechnology ETF position peaked at $208K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.